1
|
Abdullah AM, Qaradakhy AJ, Ali RM, Ali RM,
Mahmood YM, Omar SS, Nasralla HA, Muhialdeen AS, Saeed YA, Dhair HM
and Mohammed RO: Thyroid collision tumors: A systematic review.
Barw Medical J. 2:44–56. 2024.
|
2
|
Gandhi JS, Pasricha S and Gupta G:
Collision tumor of the urinary bladder comprising large cell
neuroendocrine carcinoma and adenocarcinoma. Asian J Oncol.
3:144–146. 2008.
|
3
|
Miyazaki J and Nishiyama H: Epidemiology
of urothelial carcinoma. Int J Urol. 24:730–734. 2017.PubMed/NCBI View Article : Google Scholar
|
4
|
Radović N, Turner R and Bacalja J: Primary
‘pure’ large cell neuroendocrine carcinoma of the urinary bladder:
A case report and review of the literature. Clin Genitourin Cancer.
13:375–e377. 2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Rouanne M, Loriot Y, Lebret T and Soria
JC: Novel therapeutic targets in advanced urothelial carcinoma.
Crit Rev Oncol Hematol. 98:106–115. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Ploeg M, Aben KK, Hulsbergen-van de Kaa
CA, Schoenberg MP, Witjes JA and Kiemeney LA: Clinical epidemiology
of nonurothelial bladder cancer: Analysis of the Netherlands Cancer
Registry. J Urol. 183:915–920. 2010.PubMed/NCBI View Article : Google Scholar
|
7
|
Tavora F and Epstein JI: Bladder cancer,
pathological classification and staging. BJU Int. 102:1216–1220.
2008.PubMed/NCBI View Article : Google Scholar
|
8
|
Loriot Y, Necchi A, Park SH, Garcia-Donas
J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B,
Varlamov S, et al: Erdafitinib in locally advanced or metastatic
urothelial carcinoma. N Engl J Med. 381:338–348. 2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Catto JW, Yates DR, Rehman I, Azzouzi AR,
Patterson J, Sibony M, Cussenot O and Hamdy FC: Behavior of
urothelial carcinoma with respect to anatomical location. J Urol.
177(1715)2007.PubMed/NCBI View Article : Google Scholar
|
10
|
Jiang W, Pan C, Guo W, Xu Z, Ni Q and Ruan
Y: Pathologic collision of urinary bladder urothelial carcinoma
with small cell carcinoma: A case report. Diagnostic Pathology.
18(80)2023.PubMed/NCBI View Article : Google Scholar
|
11
|
Abdullah HO, Abdalla BA, Kakamad FH, Ahmed
JO, Baba HO, Hassan MN, Bapir R, Rahim HM, Omar DA, Kakamad SH, et
al: Predatory Publishing Lists: A Review on the Ongoing Battle
Against Fraudulent Actions. Barw Med J. 2:26–30. 2024.
|
12
|
Prasad S, Nassar M, Azzam AY,
García-Muro-San José F, Jamee M, Sliman RKA, Evola G, Mustafa AM,
Abdullah HO, Abdalla BA, et al: CaReL guidelines: A consensus-based
guideline on case reports and literature review (CaReL). Barw Med
J. 2:13–19. 2024.
|
13
|
Brinton JA, Ito Y and Olsen BS:
Carcinosarcoma of the urinary bladder. A case report and review of
the literature. Cancer. 25:1183–1186. 1970.PubMed/NCBI View Article : Google Scholar
|
14
|
Chen X, Ge H, Yang J, Huang B and Liu H:
Primary malignant melanoma of the bladder collides with high grade
non invasive urothelial papillary carcinoma: A case report. Oncol
Lett. 24:1–5. 2022.PubMed/NCBI View Article : Google Scholar
|
15
|
Kitazawa M, Kobayashi H, Ohnishi Y, Kimura
K, Sakurai S and Sekine S: Giant cell tumor of the bladder
associated with transitional cell carcinoma. J Urol. 133:472–475.
1985.PubMed/NCBI View Article : Google Scholar
|
16
|
Dadhania V, Czerniak B and Guo CC:
Adenocarcinoma of the urinary bladder. Am J Clin Exp Urol.
3(51)2015.PubMed/NCBI
|
17
|
Taguchi S, Akamatsu N, Nakagawa T, Gonoi
W, Kanatani A, Miyazaki H, Fujimura T, Fukuhara H, Kume H and Homma
Y: Sarcopenia evaluated using the skeletal muscle index is a
significant prognostic factor for metastatic urothelial carcinoma.
Clin Genitourin Cancer. 14:237–243. 2016.PubMed/NCBI View Article : Google Scholar
|
18
|
Ku JH, Byun SS, Jeong H, Kwak C, Kim HH
and Lee SE: Lymphovascular invasion as a prognostic factor in the
upper urinary tract urothelial carcinoma: A systematic review and
meta-analysis. Eur J Cancer. 49:2665–2680. 2013.PubMed/NCBI View Article : Google Scholar
|
19
|
Roy S and Parwani :
AVA8/arpa.2009-0713-RS adenocarcinoma of the urinary bladder. Arch
Pathol Lab Med. 135:1601–1605. 2011.PubMed/NCBI View Article : Google Scholar
|
20
|
Lee KH and Song CG: Epigenetic regulation
in bladder cancer: Development of new prognostic targets and
therapeutic implications. Translational Cancer Res. 30
(Suppl):677–688. 2017.
|
21
|
Crabb SJ and Douglas J: The latest
treatment options for bladder cancer. Br Med Bull. 128:85–95.
2018.PubMed/NCBI View Article : Google Scholar
|
22
|
Witjes JA: Bladder carcinoma in situ in
2003: State of the Art. Eur Urol. 45:142–146. 2004.PubMed/NCBI View Article : Google Scholar
|
23
|
Mingomataj E, Krasniqi M, Dedushi K,
Sergeevich KA, Kust D and Qadir AA: Cancer Publications in one year
(2023): A cross-sectional study. Barw Med J. 2(3)2024.
|